Caravans of Americans are heading to Canada for cheaper insulin
Lija Greenseid, "a rule-abiding Minnesota mom," just led a small caravan of Americas to Canada to buy analog insulin for her 13-year-old daughter, and "she and five other Americans paid about $1,200 for drugs that would have cost them $12,000 in the United States," The Washington Post reports. As other people dealing with Type 1 diabetes and the rapidly rising price of insulin hear about her journeys north of the border, the caravan is growing — the next one will be on a chartered bus.
These drug runs to Canada — where you can buy analog insulin without a prescription, unlike in the U.S. — may be illegal. "But the organizers of the caravan — their word, a nod to the migrants traveling in groups through Mexico to the U.S. border — are speaking out about their trip because they want Americans to see how drug prices push ordinary people to extremes," the Post reports.
Canadians get the caravan reference, too. While many of them were supportive of the American caravan, others expressed concern about the supplies of Canadian insulin. "We heard a lot of comments like, 'Canada needs to put up a wall,'" said caravaner Nicole Smith-Holt. "I was like, 'Oh, come on.'"
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
The Pharmaceutical Research and Manufacturers of America (PhRMA) lobbying group blamed insurance companies for the cost of insulin, which doubled in the U.S. between 2012 and 2016, saying drug companies are increasingly offering rebates on insulin that aren't reaching patients.
Barry Power, the Canadian Pharmacists Association's director of therapeutic content, told the Post that the caravans and other cross-border drug purchasers haven't yet affected Canada's insulin supply. Canada keeps insulin prices low through a combination of price caps, negotiations with drug manufactures, and other policy, he added. "This is something the U.S. could do." Learn more at The Washington Post, or in the New York Times video op-ed below. Peter Weber
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.
-
'On arrival, workers faced a system of racial segregation'
Instant Opinion Opinion, comment and editorials of the day
By Justin Klawans, The Week US Published
-
What's the future of FEMA under Trump?
Today's Big Question The president has lambasted the agency and previously floated disbanding it altogether
By Justin Klawans, The Week US Published
-
5 helpful items to have at the ready when the power goes out
The Week Recommends Be prepared so you can stay plugged in
By Catherine Garcia, The Week US Published
-
Chinese AI chatbot's rise slams US tech stocks
Speed Read The sudden popularity of a new AI chatbot from Chinese startup DeepSeek has sent U.S. tech stocks tumbling
By Peter Weber, The Week US Published
-
US port strike averted with tentative labor deal
Speed Read The strike could have shut down major ports from Texas to Maine
By Peter Weber, The Week US Published
-
Biden expected to block Japanese bid for US Steel
Speed Read The president is blocking the $14 billion acquisition of U.S. Steel by Japan's Nippon Steel, citing national security concerns
By Peter Weber, The Week US Published
-
Judges block $25B Kroger-Albertsons merger
Speed Read The proposed merger between the supermarket giants was stalled when judges overseeing two separate cases blocked the deal
By Peter Weber, The Week US Published
-
Rupert Murdoch loses 'Succession' court battle
Speed Read Murdoch wanted to give full control of his empire to son Lachlan, ensuring Fox News' right-wing editorial slant
By Peter Weber, The Week US Published
-
Bitcoin surges above $100k in post-election rally
Speed Read Investors are betting that the incoming Trump administration will embrace crypto
By Peter Weber, The Week US Published
-
Enron mystery: 'sick joke' or serious revival?
Speed Read 23 years after its bankruptcy filing, the Texas energy firm has announced its resurrection
By Peter Weber, The Week US Published
-
US charges Indian tycoon with bribery, fraud
Speed Read Indian billionaire Gautam Adani has been indicted by US prosecutors for his role in a $265 million scheme to secure solar energy deals
By Peter Weber, The Week US Published